Membership

Membership and minutes for the Commission on Human Medicines and its expert advisory groups.

The Chair and Commissioners are appointed in accordance with the Code of Practice for Ministerial Appointments to Public Bodies, issued by the Commissioner for Public Appointments. The Chair and Commissioners follow a code of practice, in which they are precluded from holding personal interests. Their interests in the pharmaceutical industry are published in the Commission’s annual report each year.

The Commission meets monthly in London. The Commission is supported in its work by Expert Advisory Groups (EAGs), covering various areas of medicine. In addition, the Commission calls on experts not readily available through its membership.

Members and chair

Professor Stuart Ralston MB ChB MD FRCP FMedSci FRSE FFPM (Hon): Arthritis Research UK Professor of Rheumatology, University of Edinburgh, Western General Hospital, Edinburgh (Chair)

Mrs Eileen J Barrett BSc PGCE CPE LPC: Lay Member.

Dr J Colin Forfar BSc (Hons) MBChB PhD MD MA FRCP FRCP (Edin): Consultant Physician and Cardiologist, John Radcliffe Hospital, Oxford

Dr Jamie Fraser BSc MB ChB MRCGP GP Partner, Southside Surgery, Inverness

Professor Jonathan S Friedland MA PhD FRCP FRCPE FRCPI FMedSci: Hammersmith Campus Director and Head of Section of Infectious Diseases and Immunity, Imperial College London; Hon Consultant in Infectious Diseases ICHT

Dr Richard Gilson MD FRCP: Director, Centre for Sexual Health & HIV Research and Head, Research Department of Infection and Population Health, University College London

Professor Martin Gore CBE MBBS PhD FRCP: Medical Director and Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust and Professor of Cancer Medicine Institute of Cancer Research

Professor Malcolm R Macleod BSc MBChB MRCP PhD FRCP (Edin): Professor of Neurology and Translational Neurosciences, University of Edinburgh and Honorary Consultant Neurologist, NHS Forth Valley

Dr Rebecca Mann BM BS FRCPCH: Consultant Paediatrician, Taunton and Somerset NHS Foundation Trust

Dr Sarah Meredith: Deputy Director, MRC Clinical Trials Unit and Honorary Senior Lecturer, Department of Primary Care and Population Sciences, University College London

Dr Siraj Misbah MBBS (Hons) MSc FRCP FRCPath: Consultant Clinical Immunologist, Lead for Clinical Immunology, Oxford University Hospitals

Professor David G C Owens MD (Hons) FRCP FRCPsych Professor of Clinical Psychiatry, Edinburgh University

Professor Sir Munir Pirmohamed MB ChB (Hons) PhD FRCP FRCP (E) FBPhS FMedSci, Professor of Clinical Pharmacology, University of Liverpool, NHS Chair of Pharmacogenetics and Director of the Wolfson Centre for Personalised Medicine

Professor Shirley Price MSc PhD FBTS ERT FHEA FSB Head of Academic Appeals and Academic Quality and Professor of Toxicology, University of Surrey

Professor Kevin M G Taylor BPharm PhD MRPharmS Chair of the British Pharmacopoeia Commission and Professor of Clinical Pharmaceutics, UCL School of Pharmacy, London

Professor Angela E Thomas MB BS PhD FRCPE FRCPath FRCPCH (Vice Chair) Consultant Paediatric Haematologist, Royal Hospital for Sick Children, Edinburgh

Professor Helen M Ward MSc, BSc (Hons), RGN, RCN Nurse Practitioner, PGCEA, PG Cert NMP Associate Professor, Non-Medical Prescribing, London South Bank University

Professor Christopher Weir BSc (Hons) PhD MSc FRSS C.Stat C. Sci Personal Chair in Medical Statistics and Clinical Trials, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh

Dr Martin Wilson MRCP (UK) MPhil (Glasgow), FRCP(Edin) Consultant Physician in Care of the Elderly, Raigmore Hospital, Inverness

Summary minutes

Summary minutes are prepared on the basis that no personal, commercial or otherwise confidential information is disclosed.

See the final summary minutes for CHM and EAGs from 2014 onwards, which you can download.

Previous minutes can be seen on the MHRA pages on the National Archives

Code of practice for chairmen and members of the commission on human medicines, certain committees and expert advisory groups (PDF, 103KB, 15 pages)

Meeting dates

2016

Jan Feb March April May June July Sept Oct Nov Dec
21/ 22 18/ 19 24 21/ 22 19/ 20 16 / 17 14/ 15 8/ 9 6/ 7 3/ 4 8/ 9

2017

Jan Feb March April May June July Sept Oct Nov Dec
19/20 16/17 16/17 13/14 11/12 15/16 13/14 7/8 5/6 2/3 7/8

2018

Jan Feb March April May June July Sept Oct Nov Dec
18/19 15/16 15/16 19/20 24/25 21/22 19/20 13/14 11/12 8/9 6/7

Infection EAG

Remit

To advise the Commission on the safety and efficacy of medicines for use in infections including HIV, AIDS and viral hepatitis.

Chair

Professor Jonathan S Friedland MA PhD FRCP FRCPE FRCPI FMedSci Hammersmith Campus Director & Head of Section of Infectious Diseases & Immunity, Imperial College London; Hon Consultant in Infectious Diseases ICHT

Members

Professor David Dockrell MB BCh MD FRCPI FRCP (Glas) FACP Professor of Infectious Diseases, Medical School, University of Sheffield

Dr Andrew Freedman B.A M.B,B.Chir M.A M.D FRCP FRCP Reader in Infectious Diseases, Cardiff University School of Medicine/ Hon. Consultant Physician, University Hospital of Wales

Dr Richard Gilson MD FRCP Director, Centre for Sexual Health & HIV Research and Head, Research Department of Infection and Population Health, University College London

Dr Richard Hobson MB BS MRCP (UK) FRCPath PhD Consultant Microbiologist and Honorary Senior Lecturer, Leeds Teaching Hospitals

Dr Susan Hopkins MB ChB BAO (Hons) BA FRCPI Consultant in Infectious Diseases and Microbiology, Royal Free Hampstead NHS Trust, Healthcare Epidemiologist, Health Protection Agency, Honorary Senior Lecturer, University College London

Dr Hermione Lyall BSc Hons MB ChB Hons MD FRCPCH Consultant in Paediatric Infectious Diseases, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London

Professor Kevin Moore BSc MB BS PhD FRCP Professor of Hepatology, Royal Free Hospital, London

Professor Robert C Read MBChB BMedSci MRCP MD FRCP Professor of Infectious Diseases and Head of Academic Unit, Clinical Experimental Science, University of Southampton

Ms Hilary A Shenton CPFA Lay Representative. Retired Secretary to the School of Medicine, University of Sheffield

Professor Martin Lombard MD MSc FRCP (Lond) Consultant Hepatologist & Gastroenterologist, Royal Liverpool University Hospitals NHS Trust

Cardiovascular, Diabetes, Renal, Respiratory and Allergy EAG

Remit

To advise CHM on the safety and efficacy of medicines for used for the treatment and prevention of cardiovascular, diabetes, renal, respiratory and allergy diseases.

Chair

Dr J Colin Forfar BSc (Hons) MBChB PhD MD MA FRCP FRCP (Edin) Consultant Physician and Cardiologist, John Radcliffe Hospital, Oxford

Members

Dr Amanda Adler MD, PhD, FRCP Consultant Physician, Diabetes, Addenbrooke’s Hospital, Cambridge University Hospitals

Dr Iolo J Doull MRCP DM FRCPCH Consultant Respiratory Paediatrician, Respiratory/Cystic Fibrosis Unit, Children’s Hospital for Wales, Cardiff

Dr John Firth BA BM ChB DM FRCP Consultant Physician and Nephrologist, Addenbrooke’s Hospital, Cambridge

Dr Andrew Grace MB PhD FRCP FACC FESC Consultant Cardiologist, Papworth and Addenbrooke’s Hospitals Cambridge & Research Group Head, Department of Biochemistry, University of Cambridge

Professor Wasim Hanif MBBS MD FRCP Professor of Diabetes & Endocrinology, Consultant Physician and Clinical Director of Diabetes, University Hospital Birmingham

Dr Philip W Ind BA Cantab MB BChir MA Cantab FRCP Consultant Physician and Honorary Senior Lecturer in Respiratory Medicine, Imperial School of Medicine, Hammersmith Hospital

Professor Alan G Jardine BSc MD FRCP Professor of Renal Medicine, University of Glasgow

Professor Ann Millar MBChB MD FRCP (Vice Chair) Professor in Respiratory Medicine, Bristol University & Honorary Consultant, North Bristol NHS Trust

Dr Hilary Pinnock MB ChB (Hons) MRCGP MD Reader, Asthma UK Centre for Applied Research, Allergy and Respiratory Research Group, University of Edinburgh; General Practitioner, Whitstable Medical Practice

Dr Pallav L Shah MD MBBS FRCP Consultant Physician, Royal Brompton Hospital and Chelsea & Westminster Hospital, Reader in Respiratory Medicine, Imperial College

Dr Caroline Vaughan PhD Lay Representative of MHRA EAGS. Trustee and Director of Contact a Family and FamilyLine

Mr Phil Willan MSc Lay Representative. Member of Pharmacovigilance EAG; Member of the Royal College of Physicians’ (RCP) Patient and Carer Network; Member of the RCP Joint Speciality Committee (JSC) for Renal Medicine, Healthcare Associated Infections Working Group, Specialist Advisory Committee for Renal Medicine, JSC for Allergy and Immunology, Faculty of Forensic and Legal Medicine, Federation CPD Policy Committee and Equality and Diversity Monitoring Committee

Professor Sarah Wild MB BChir MSc PhD FRCPE FFPH, Professor of Epidemiology, Honorary Consultant in Public Health, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh

Meeting dates

Chemistry, Pharmacy and Standards EAG

Remit

To advise the CHM on the quality in relation to safety and efficacy of medicinal products which are the subject of marketing authorisation applications and to advise on such other matters as are referred to it.

Chair

Professor Kevin M G Taylor BPharm PhD FRPharmS Chair of the British Pharmacopoeia Commission and Professor of Clinical Pharmaceutics, UCL School of Pharmacy, London

Members

Dr Majella Lane BSc PhD Senior Lecturer in Pharmaceutics, University College London - School of Pharmacy

Professor Michael E Aulton BPharm PhD FRPharmS FAAPS FSP Emeritus Professor, De Montfort University, Leicester

Professor Graham Buckton BPharm PhD DSc FRPharmS FRSC Professor of Pharmaceutics, UCL School of Pharmacy

Professor Derek Calam OBE MA DPhil Hon DSc CChem FRSC FRSA Hon MRPharmS Hon MTOPRA Visiting Professor of Pharmaceutical Sciences at the University of Strathclyde

Professor Brian J Clark MSc PhD CChem FRSC Professor of Pharmaceutical and Biomedical Analysis, Bradford University

Professor Ruth Duncan PhD Professor Emerita in Cell Biology and Drug Delivery, Cardiff University and Visiting Professor at the University of Greenwich

Mr V’Iain G Fenton-May BPharm MIPharm FRPharmS Pharmaceutical Microbiologist

Professor Geoffrey W Hanlon BSc PhD MRPharmS Emeritus Professor of Pharmaceutical Microbiology, School of Pharmacy & Bio-Molecular Sciences, University of Brighton

Dr Gillian M Hawksworth MBE PhD FFRPS FRPharmS (Hon) DSc Academic Community Pharmacist, Visiting Lecturer at University of Huddersfield & Past President of the RPSGB

Miss Carol E Knott MRPharmS MBA MIHM Lay Representative. Director of Windcliff Management Ltd

Mr Robert Lowe BPharmS MRPharmS Practising Hospital Pharmacist, NHS Eastern Region

Professor Christopher Marriott PhD DSc Hon DSc FRPharmS CChem FRSC FRSM (Vice Chair) Emeritus Professor of Pharmaceutics, King’s College, London

Professor Yvonne Perrie BSc Hons MRPharmS FAPS FSB PhD Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde.

Ms Hilary A Shenton CPFA Lay Representative. Retired Secretary to the School of Medicine, University of Sheffield

Professor Michael D Threadgill PGCE MA PhD DSc FRSC CChem Professor in Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath

Professor Peter York PhD BSc DSc FRPharmS CChem FRSC FAAPS Emeritus Professor of Pharmaceutics, Bradford University

Meeting dates

2016

Jan Feb March April May June July Sept Oct Nov Dec
19 16 22 19 17 14 12 6 4 1 6

2017

Jan Feb March April May June July Sept Oct Oct Dec
17 14 14 11 9 13 11 5 3 31 5

2018

Jan Feb March April May June July Sept Oct Nov Dec
16 13 13 17 22 19 17 11 9 6 4

Clinical Trials, Biologicals and Vaccines EAG

Remit

To advise the CHM on:

  • first time in human (FTIM) studies with new compounds acting (directly or indirectly) via the immune system with a novel target or a novel mechanism of action or having a secondary potential effect on the immune system via a mechanism of action which currently is not well characterised.
  • FTIM studies with novel compounds acting via a possible or likely species specific mechanism
  • Any FTIM studies which are otherwise seen as requiring expert advice
  • Other clinical trials involving classes of compound where MHRA may wish to seek external expert advice or CHM may wish to have oversight
  • Whether a product’s mechanism of action is novel and comes within the scope of the EAG
  • Pre-meeting scientific advice documentation for within scope compounds
  • Other clinical trials where MHRA may wish to seek advice or where there is a difficult risk benefit balance
  • Other clinical trials involving products where a new class safety issue has been identified
  • The quality, safety and efficacy of medicinal products of biological or biotechnological origin including vaccines which are the subject of marketing authorisation applications; and to advise on such other matters as are referred to it

Chair

Professor Angela E Thomas MB BS PhD FRCPE FRCPath FRCPCH Consultant Paediatric Haematologist, Royal Hospital for Sick Children, Edinburgh

Members

Professor Andrew J T George MA PhD DSc FRCPath FHEA FRSA FSB Vice Principal (Education and International), Brunel University, London

Dr Elwyn Griffiths BSc PhD DSc CChem FRSC Consultant in Biologicals and Vaccines, World Health Organization; Formerly Director General, Biologics and Genetic Therapies Directorate, Health Canada, Ottawa, Canada

Dr Helen J Lachmann MD FRCP (Vice Chair) Reader and Honorary Consultant in Amyloidosis and Renal Medicine, University College London

Professor Elizabeth Miller OBE BSc MBBS FRCPath FFPHM FMedSci Consultant Epidemiologist, Immunisation Department, Centre for Infections, Health Protection Agency

Dr Siraj Misbah MBBS (Hons) MSc FRCP FRCPath Consultant Clinical Immunologist, Lead for Clinical Immunology, Oxford University Hospitals

Professor B Kevin Park BSc PhD FMedSci FRCP (Hon) FBTS Director of MRC Centre for Drug Safety Science, Professor of Pharmacology & Head of Institute of Translational Medicine, University of Liverpool

Professor Andrew Pollard PhD FRCPCH Chair of the Joint Committee on Vaccination and Immunisation; Professor of Paediatric Infection and Immunity, University of Oxford

Dr Stephen Poole PhD Consultant: Biological Medicines and Vaccines

Dr Peter F Searle BA PhD Senior Lecturer, School of Cancer Sciences, University of Birmingham

Mrs Madeleine Wang BA (Hons) Lay Representative. Patient Advocate

Professor Christopher Weir BSc (Hons) PhD MSc FRSS C.Stat C. Sci Personal Chair in Medical Statistics and Clinical Trials, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh

Meeting dates

2016

Jan Feb March April May June July Sept Oct Oct Dec
18 15 21 18 16 13 11 5 3 31 5

2017

Jan Feb March April May June July Sept Oct Nov Dec
16 13 13 10 8 12 10 4 2 30 4

2018

Jan Feb March April May June July Sept Oct Nov Dec
15 12 12 16 21 18 16 13 10 8 5

Gastroenterology, Rheumatology, Immunology and Dermatology EAG

Remit

To advise the CHM on the safety and efficacy of medicines for use in gastroenterological, rheumatological, immunological, and dermatological diseases.

Chair

Professor Anthony G Wilson MB BCH BAO DCH PhD FRCP Professor of Rheumatology, Medical School, University of Sheffield

Members

Dr Michael Ardern-Jones BSc MBBS DPhil FRCP Associate Professor, University of Southampton and Consultant Dermatologist

Dr Ian Barrison BSc MB FRCP FEBGH President European Board of Gastroenterology and Hepatology; Associate Dean, Postgraduate Medicine, School of Life and Medical Sciences, University of Hertfordshire

Mr David Chandler Lay Representative. Chief Executive, Psoriasis and Psoriatic Arthritis Alliance, Hertfordshire

Dr Richard Groves MB BS MRCP FRCP Consultant Dermatologist, St John’s Institute of Dermatology, Guy’s and St Thomas Hospital

Professor Kevin Moore BSc MB BS PhD FRCP Professor of Hepatology, Royal Free Hospital, London

Dr Frances Williams BSc MBBS MRCP PhD CCST FRCP (Edin) Reader in Genetic Epidemiology and Hon Consultant Rheumatologist, King’s College London

Meeting dates

Medicines for Women’s Health EAG

Remit

To advise the CHM on the safety and efficacy of medicines related to endocrinology and women’s reproductive health from menarche to menopause and conditions related to the menopause, such as osteoporosis. The medicines covered will include medicines for contraception, emergency contraception and termination of pregnancy; medicines for infertility and assisted conception; hormone replacement therapy (HRT) and non-hormonal treatments for osteoporosis.

Chair

Dr Ailsa Gebbie MB ChB FRCOG FRCPE FFSRH Consultant Gynaecologist and Deputy Director, Chalmers Centre, Edinburgh

Members

Carolyn, Lady Roberts HV Cert. MSc D Univ Member of The Ethox Foundation - Oxford Centre for Ethics and Communication in Healthcare Practice

Dr E Jane Dickson MB BChir FSRH Consultant in Sexual and Reproductive Healthcare Contraception, Sexual Health and Community Gynaecology, Oxleas NHS Foundation Trust

Professor Philip Hannaford MB ChB DRCOG DCH MD FRCGP FFSRH FFPH Professor of Epidemiology, University of Aberdeen

Professor Mary Lumsden BSc MB BS MD FRCOG (Vice Chair) Professor of Medical Education & Gynaecology, University of Glasgow

Ms Linda Pepper BA MA (Education) Independent Consultant: patient and public involvement in healthcare

Professor Siobhan Quenby MBBS BSc MD FRCOG Professor of Obstetrics, Warwick University

Dr Clare Spencer MA MB BCHIR DM MRCOG MRCGP DFFPRHC GP Partner

Professor Jonathan H Tobias BA (Cantab) MBBS PhD (London) FRCP MD (London) Professor of Rheumatology, University of Bristol, and Honorary Consultant Rheumatologist, North Bristol Trust

Commission on Human Medicines Observer

Carolyn, Lady Roberts HV Cert. MSc D Univ, Member of The Ethox Foundation - Oxford Centre for Ethics and Communication in Healthcare Practice

Meeting dates

Neurology, Pain and Psychiatry EAG

Remit

To advise the CHM on the safety and efficacy of medicines for use in neurological conditions, pain management and psychiatric conditions.

Chair

Professor David G C Owens MD (Hons) FRCP FRCPsych Professor of Clinical Psychiatry, Edinburgh University

Members

Dr Waqar Rashid MBBS BSc MRCP(UK) PhD Consultant and Honorary Clinical Senior Lecturer in Neurology, Brighton and Sussex University Hospitals NHS Trust, member of the Multiple Sclerosis Society

Dr Anthony L Johnson BSc PhD CStat Honorary Senior Research Associate, MRC Clinical Trials Unit at UCL, London

Professor Malcolm R Macleod BSc MBChB MRCP PhD FRCP (Edin) (Vice Chair) Professor of Neurology and Translational Neurosciences, University of Edinburgh and Honorary Consultant Neurologist, NHS Forth Valley

Professor John T O’Brien BA MA BMBCh DM FRCPsych Professor of Old Age Psychiatry, University of Cambridge

Dr Catherine F Stannard MB ChB FRCA FFPMRCA Pain Clinic Macmillan Centre, Frenchay Hospital, Bristol

Professor Eric A Taylor MA MB FRCP FRCPsych (Hon) FMedSci Emeritus Professor of Child & Adolescent Psychiatry, King’s College London Institute of Psychiatry

Professor Christopher Weir BSc (Hons) PhD MSc FRSS C.Stat C. Sci Personal Chair in Medical Statistics and Clinical Trials, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh

Meeting dates

Oncology and Haematology EAG

Remit

To advise the CHM on the safety, quality and efficacy of medicines used in the treatment of malignant disease or blood disorders.

Chair

Professor Martin Gore CBE MBBS PhD FRCP Medical Director and Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust and Professor of Cancer Medicine, Institute of Cancer Research

Members

Professor Mark D Bower MA MB BChir PhD FRCP FRCPath Consultant Medical Oncologist, Chelsea & Westminster Hospital, London

Professor Stephen Devereux PhD FRCP FRCPath Consultant Haematologist, Kings College Hospital

Dr Chris Gallagher BSc PhD FRCP Consultant Medical Oncologist, St Bartholomew’s Hospital, Barts and the London NHS Trust

Professor Angela E Thomas MB BS PhD FRCPE FRCPath FRCPCH Consultant Paediatric Haematologist, Royal Hospital for Sick Children, Edinburgh

Invited expert

Professor A Hilary Calvert MB BChir MSc MD FRCP FMedSci Director of Cancer Drug Discovery and Development, UCL Cancer Institute

Meeting dates

2016

April May June July Sept
11 9 1 18 26

Paediatric Medicines EAG

The remit of the EAG is to advise the CHM on the safety, quality and efficacy of medicines for paediatric use, including all matters relating to the implementation of the EU Paediatric Regulation.

Chair

Dr Rebecca Mann BMBS FRCPCH Consultant Paediatrician, Taunton and Somerset NHS Foundation Trust

Members

Dr Eileen M Baildam MB ChB DRCOG DCH RCP FRCP FRCPCH Consultant Paediatric Rheumatologist and Honorary Senior Lecturer, Alder Hey Foundation NHS Trust and University of Liverpool

Dr Helen Burdett MB ChB MRCP FRCA Consultant Anaesthetist, Tunbridge Wells Hospital

Professor J Helen Cross MB ChB PhD FRCP FRCPCH, the Prince of Wales’s Chair of Childhood Epilepsy, Deputy Head of Developmental Neurosciences Programme, UCL Institute of Child Health

Professor Steven Cunningham MBChB PhD FRCPCH (Vice Chair) Consultant and Honorary Professor in Paediatric Respiratory Medicine, NHS Lothian Royal Hospital for Sick Children and University of Edinburgh

Professor Peter C Hindmarsh BSc MD FRCP FRCPCH Consultant Paediatric Endocrinologist, Royal Free and University College Medical School

Dr Meriel Jenney MBChB MRCP MD FRCPCH Consultant Paediatric Oncologist/Assistant Medical Director (Cancer Services), Children’s Hospital for Wales

Professor Nigel Klein BSc MBBS MRCP PhD FRCPCH Consultant, Great Ormond Street Hospital for Children NHS Trust; Professor of Infectious Diseases and Microbiology, Institute of Child Health, UCL

Dr Rubin Minhas MB ChB MBA GP Principal

Professor Marie-Louise Newell MB MSc PhD FMedSci Professor of Global Health, Academic Unit of Human Development and Health, Faculty of Medicine, University of Southampton

Professor Anthony Nunn BPharm FRPharmS Hon FRCPCH Honorary Fellow, Department of Women’s and Children’s Health, University of Liverpool; Industry Professor, School of Pharmacy and Biomedical Sciences, Liverpool John Moores University, Alder Hey Children’s Hospital, Liverpool

Ms Sara Payne BA CPE LPC Lay Representative. Solicitor

Dr Jane Tizard MBBS FRCP FRCPCH Consultant Paediatric Nephrologist, Bristol Royal Hospital for Children

Dr Beverly Tsai-Goodman MD FRCP PG Cert Med Ed Consultant Paediatric and Fetal Cardiologist, Bristol Children’s Hospital and Deputy Dean for South Bristol Academy, University of Bristol Medical School

Dr Catherine L C Tuleu PhD Cert Ed MRPharmS Reader in the Department of Pharmaceutics, Director of the Centre for Paediatric Pharmacy Research, UCL School of Pharmacy

Professor Heather M Wallace PhD FRCPath FRSC FSB FBPharmacolS FBTS European Registered Toxicologist Professor of Biochemical Pharmacology and Toxicology, Division of Applied Medicine, University of Aberdeen

Mrs Madeleine Wang BA (Hons) Lay Representative. Patient Advocate

Dr Mark Whiting BNursing MSc PhD Consultant Nurse, Children’s Community and Specialist Nursing, Peace Children’s Centre, Hertfordshire Community NHS Trust

Dr Morris Zwi MB BCh FRCPsych Consultant Child & Adolescent Psychiatrist & Clinical Lead, Child & Adolescent Mental Health Services, Whittington Health, Clinical Lead for Islington Child & Adolescent Mental Health Services

Meeting dates

2016

Jan Feb March April May June July Aug Sept Sept Oct Dec
12 11 17 13 10 9 8 3 1 28 25 1

2017

Jan Feb March April May June July Aug Sept Oct Nov
10 8 7 6 3 6 4 2/29 26 25 30

2018

Jan Feb March April May June July Aug Sept Oct Nov
10 6 6 11 16 12 10 9 4 3/30 29

Patient and Public Engagement EAG

The remit of the EAG will be to advise the Commission on Human Medicines (CHM) on:

  • the development of effective communications for patients, the public and carers to help them make informed choices about medicines and to use medicines safely
  • how to improve communication between patients and health professionals and between the MHRA and the public on the safe use of medicines
  • ways to promote the availability and accessibility of high quality information about individual medicines available in the UK
  • ways to encourage reporting of adverse drug reactions (ADRs) by patients and the public - recognising the importance of the patient experience, to advise on building links between patient concerns as experienced in direct ADR reports and the information provided to patients
  • facilitating targeted patient involvement on relevant regulatory issues, where patient/public involvement has not otherwise been achieved by working with specific patient organisations
  • providing a patient perspective on strategic issues such as the upcoming European legislation on Patient Information

Chair Pro Tem

Mr Phil Willan MSc (Vice-Chair) Lay Representative. Member of the Royal College of Physicians (RCP) Patient and Carer Network; Member of the RCP Joint Speciality Committee (JSC) for Renal Medicine, Healthcare Associated Infections Working Group, Specialist Advisory Committee for Renal Medicine, JSC for Allergy and Immunology, Faculty of Forensic and Legal Medicine, Federation CPD Policy Committee and Equality and Diversity Monitoring Committee

Members

Ms Hellen Adom BA MA Lay Member. Outreach Assistant, NHS Sickle Cell & Thalassaemia Screening Programme, London

Mr David Chandler Lay Member. Chief Executive, Psoriasis and Psoriatic Arthritis Alliance, Hertfordshire

Mr John Chapman LL.B (Lon) Lay Member. Patient/Carer Member

Mrs Joyce Epstein Lay Member. Former Director of the Foundation for the Study of Infant Deaths (FSID)

Dr Nicola Jane Gray PhD MRPharmS FHEA FSAHM (US) Lay Member. Independent Pharmacist Researcher, Manchester

Ms Amanda Hoey Lay Member. Director, ConsumerHealth Consulting Ltd. Independent Health Policy and Strategy Consultant

Mrs Farrah Pradhan Lay Member. Invited Reviews Coordinator at the Royal College of Obstetricians and Gynaecologists

Mrs June Rogers MBE RN RSCN BA (Hons) MSc Lay Member. PromoCon Paediatric Advisor, Disabled Living

Dr Bella Starling PhD BSc Hons Dip Lay Member. Director of Public Programmes, Nowgen, a Centre for Genetics in Healthcare

Mr Paddy Storrie MA (Oxon) NPQH Lay Member. Deputy Headmaster, St. George’s School, Hertfordshire and Lay Member, N.I.C.E Technology Appraisals Committee

External experts

Mrs Anne Joshua BPharm (Hons) MSc Pharm Dip MRPharmS NHS 111 Pharmacy Lead, NHS England

Professor Angus Mackay OBE MA PhD (Cantab) MB ChB BSc (Pharmacol) FRCP (Edin) FRCPsych TPsych Professor of Psychological Medicine, University of Glasgow

Professor D K Theo Raynor BPharm (Hons) PhD MRPharmS Professor of Pharmacy Practice, University of Leeds

Invited observers

Carolyn, Lady Roberts HV Cert. MSc D Univ, Member of The Ethox Foundation - Oxford Centre for Ethics and Communication in Healthcare Practice

Pharmacovigilance EAG

Remit

To advise the CHM on the following in relation to human medicines including herbal products:

  • the public health importance of potential new signals
  • the confirmation and quantification of risks identified
  • appropriate risk minimisation measures including communications
  • design and progress of pharmacovigilance plans
  • methodologies for pharmacovigilance.

Chair

Professor Sir Munir Pirmohamed MB ChB (Hons) PhD FRCP FRCP (E) FBPhS FMedSci, Professor of Clinical Pharmacology, University of Liverpool, NHS Chair of Pharmacogenetics and Director of the Wolfson Centre for Personalised Medicine

Members

Dr Robert C G Bracchi BSc MB BCh MD FRCGP General Practitioner and Honorary Senior Lecturer, Cardiff University

Professor Jamie Coleman MD MA (Med Ed) FRCP FBPhS Professor in Medical Education / Consultant Clinical Pharmacologist, University of Birmingham

Professor William Dixon MRCP PhD MRC Clinician Scientist and Honorary Consultant Rheumatologist, The University of Manchester

Dr Ian J Douglas BSc MSc PhD Senior Lecturer in Pharmacoepidemiology, London School of Hygiene & Tropical Medicine

Professor Alison B Ewing BSc MSc MIPharmM FFRRPS FRPharmS Clinical Director of Pharmacy, Royal Liverpool and Broadgreen University Hospital NHS Trust; Professor of Pharmacy Innovation, Liverpool John Moores University

Ms Amanda Lee RGN RM RNP MSc (NURS) BSc (Hons) Dip HEd PG Cert ANNP PhD student & Academic Lecturer Health Professional Studies, University of Hull

Professor Glyn Lewis BA MSc MB BS MRCPsych PhD Professor of Psychiatric Epidemiology, University College London

Professor Simon R J Maxwell MD PhD FRCP FRCPE FBPharmacolS FHEA Professor of Student Learning/Clinical Pharmacology, Western General Hospital, Edinburgh & University of Edinburgh

Dr Karen Miller BSc MBBS DRCOG DCH DFFP FRCGP GP Partner, Adelaide Medical Centre, London

Dr Nicholas J Plant BSc PhD Reader in Molecular Toxicology, University of Surrey

Dr Ruben Thanacoody MD FRCP FRCP (Edin) Consultant Physician, Royal Victoria Infirmary; Honorary Clinical Senior Lecturer, Institute of Cellular Medicine, Newcastle University

Dr Caroline Vaughan PhD Lay Representative of MHRA EAGS. Trustee and Director of Contact a Family and FamilyLine

Mr Phil Willan MSc Lay Representative. Member of the Royal College of Physicians (RCP) Patient and Carer Network; Member of the RCP Joint Speciality Committee (JSC) for Renal Medicine, Healthcare Associated Infections Working Group, Specialist Advisory Committee for Renal Medicine, JSC for Allergy and Immunology, Faculty of Forensic and Legal Medicine, Federation CPD Policy Committee and Equality and Diversity Monitoring Committee.

Meeting dates

2016

Jan Feb March April May June Aug Sept Oct Nov
6 3 9 6 4 1/29 24 21 19 23

2017

Jan Feb March April May June Aug Sept Oct Nov
4 1 1/29 26 31 28 23 20 18 22

2018

Jan Feb April May June Aug Sept Oct Nov
3/31 28 4 9 6/27 29 26 24 21